Onderneming Spark Therapeutics Inc Nasdaq
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 01-05-17 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 25-09-17 | |
Blake Sprayberry
PRN | Corporate Officer/Principal | - | - |
Chris Stevens
PRN | Corporate Officer/Principal | - | 01-01-22 |
Corporate Officer/Principal | - | 01-01-17 | |
Corporate Officer/Principal | - | 16-11-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 17-12-19 |
Bruce Resnick
BRD | Director/Board Member | - | 17-12-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 38 944 971 | 36 835 813 ( 94,58 %) | 421 677 ( 1,083 %) | 94,58 % |
Bedrijfsgegevens
Spark Therapeutics, Inc.
3737 Market Street Suite 1300
19104, Philadelphia
+215 220 9300
http://www.sparktx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,33% | 104 mld. | |
+4,97% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-13,49% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,67% | 16,36 mld. | |
+8,61% | 14,39 mld. | |
+40,63% | 12,37 mld. |